Keytruda for Squamous Cell Carcinoma User Reviews
Keytruda has an average rating of 7.8 out of 10 from a total of 5 reviews for the treatment of Squamous Cell Carcinoma. 80% of reviewers reported a positive experience, while 20% reported a negative experience.
- Arc...
- Taken for 6 months to 1 year
- January 13, 2025
"After 3 months, my squamous cell carcinoma completely disappeared. Monitoring PET scans have not shown any cancer recurrence for the past 6 months. I am beginning to experience joint pain, tiredness, and a general feeling of malaise. I intend to discontinue use in another month if the next PET scan is still cancer-free."
- Kim...
- Taken for 2 to 5 years
- January 10, 2025
"All the tumors on my lymph nodes are no longer visible. Infusion every 3 weeks, 1/2 hour long. Low energy seems to be the side effect. Stage 4 cancer seems to be gone. Nothing visible in numerous scans."
Frequently asked questions
- What is the success rate of Keytruda?
- How long does it take for Keytruda to work?
- What are monoclonal antibodies?
- What is the difference between Opdivo and Keytruda?
- Amn...
- Taken for 6 months to 1 year
- August 3, 2023
"Have not noticed any side effects so far. Been on Keytruda for 6 months. Originally in combination with Carboplatin/Pax and for the last 2 months only Keytruda. Couldn't get it approved to start sooner. My hope is it will keep the remaining tumors in check and maybe even kill them (Stage 4 anal/vaginal)"
- Bil...
- Taken for less than 1 month
- August 27, 2023
"Initially no adverse effects. After 4-5 days, extreme tiredness, feeling weak, especially in my hands. After a week or so, I developed a low-grade fever up to 102 and more of a cough. I called the treatment center, and they said this is not a Keytruda side effect. I took a COVID test, and it was negative. I assume I just have a cold or flu? I have not had a cold or flu of any kind for at least 8-9 years. The swellings in my neck are going down. This was my first injection."
More about Keytruda (pembrolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (245)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"We found out my dad had squamous cell lung cancer stage 4 in June. He tried radiation, which didn't work. Doctors didn't suggest chemo but suggested immunotherapy Keytruda instead. I had really high hopes for immunotherapy after reading and seeing good things about it on ABC News claiming it could be the 'cure.' My family and I definitely had high hopes, and we all thought it would be safer than chemo with fewer side effects. August 24th, 2022, Wed is when they gave Keytruda to him through IV. I saw him the next day, and he seemed fine in the hospital despite his other health problems and his legs being paralyzed from the tumor. Sunday, I called the hospital to check on how he was doing. Nurses said he wasn't doing good, somehow his oxygen was depleting in his body, and he wasn't responding to their oxygen. I rushed to the hospital Aug 28th, Sun, and saw my dad for the last time, held his hand while I watched him breathe his last breath unconscious. He was starved of oxygen because of this..."